Should atorvastatin be continued on the day of surgery in an adult patient without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can atorvastatin be taken before surgery?

Yes, atorvastatin should be continued on the day of surgery in patients already taking it, and discontinuation is potentially harmful. 1

Primary Recommendation: Continue Statins Perioperatively

The 2014 ACC/AHA perioperative guidelines provide a Class I recommendation (Level of Evidence: B) that statins should be continued in patients currently taking statins and scheduled for noncardiac surgery 1. This is the strongest level of recommendation, meaning the benefit substantially outweighs the risk.

The most recent 2024 AHA/ACC guidelines reinforce this with an even stronger Class 1, Level B-NR recommendation that continuation of statin therapy is recommended to reduce the risk of major adverse cardiovascular events (MACE) 2.

Why Continuation is Critical

Discontinuation of statins causes a rebound effect that is disadvantageous 3. Multiple guidelines emphasize that patients in whom statins were discontinued after surgery have shown higher mortality rates than those in whom statins were continued postoperatively 4.

The European Heart Journal guidelines specifically note that "discontinuation of statins may cause a rebound effect and be disadvantageous" and recommend statins with long half-lives like atorvastatin to bridge the period immediately after surgery when oral intake may not be feasible 3.

Evidence Supporting Perioperative Statin Use

Mortality and Cardiac Event Reduction

  • A meta-analysis of 223,010 patients showed statins reduced mortality by 44% in non-cardiac surgery and 59% in vascular surgery 3
  • In vascular surgery patients, atorvastatin 20 mg daily significantly reduced cardiac events (8% vs 26%, P=0.03) over 6 months 3
  • Large observational trials demonstrated lower crude mortality rates in patients receiving perioperative statins 1

Mechanism of Benefit

Beyond lipid-lowering, statins provide pleiotropic effects that prevent plaque rupture and subsequent MI in the perioperative period through coronary plaque stabilization, decreased inflammation, and reduced oxidation 3.

Addressing Safety Concerns

Myopathy and Rhabdomyolysis Risk

While theoretical concerns exist about statin-induced myopathy during surgery, actual evidence does not support withholding statins:

  • A 2002 ACC/AHA/NHLBI advisory suggested it "probably is prudent to withhold statins during" major surgery 5
  • However, no studies have been published that support this concern, except for some case reports 3
  • A retrospective study of 981 consecutive vascular surgery patients found no cases of rhabdomyolysis, significantly higher creatine kinase levels, or increased incidence of myopathy in statin users 3

Important Caveat from Recent Evidence

One randomized trial (2016) found that high-dose perioperative atorvastatin in statin-naïve patients, particularly those with chronic kidney disease (eGFR <60 mL/min/1.73 m²), was associated with increased AKI 6. However, this applies to initiating high-dose statins perioperatively, not continuing existing therapy.

FDA Label Guidance

The FDA label for atorvastatin states to "temporarily discontinue atorvastatin calcium tablets in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis (e.g., sepsis; shock; severe hypovolemia; major surgery; trauma)" 7.

However, this FDA warning is superseded by higher-quality guideline evidence showing that continuation is beneficial and discontinuation is harmful. The FDA label reflects theoretical concerns not borne out in clinical trials.

Practical Management Algorithm

For patients already on atorvastatin:

  1. Continue atorvastatin through the day of surgery
  2. Resume as soon as oral intake is feasible postoperatively
  3. Do NOT hold the medication due to theoretical myopathy concerns
  4. Monitor for muscle symptoms if patient has additional risk factors (renal impairment, multiple interacting medications)

For statin-naïve patients:

  • The 2024 guidelines recommend initiating statins in patients who meet criteria for statin use based on ASCVD history or 10-year risk assessment, with intention of long-term use 2
  • However, initiating high-dose statins immediately before surgery (particularly in patients with renal impairment) should be avoided based on the 2016 RCT data 6

Key Pitfalls to Avoid

  1. Do not discontinue statins "to be safe" - this increases risk of perioperative cardiac events
  2. Do not confuse continuation with initiation - continuing existing therapy is beneficial; starting high-dose therapy in statin-naïve patients may be harmful
  3. Atorvastatin's long half-life is advantageous - it bridges periods when oral intake is not possible 3
  4. Resume statins as soon as possible postoperatively - delays in resumption increase mortality 4

References

5
Guideline

acc/aha/nhlbi clinical advisory on the use and safety of statins.

Journal of the American College of Cardiology, 2002

Related Questions

Should I take Atorvastatin (Atrova) before surgery?
Should statins be held in patients with Acute Kidney Injury (AKI)?
At what age can statins be used in an 85-year-old woman with total cholesterol of 235 mg/dL and high cardiovascular risk?
What precautions, contraindications, and monitoring parameters should be considered when prescribing atorvastatin?
What are the adverse effects of high‑dose atorvastatin (≥80 mg daily)?
For an 81-year-old woman with a nontender left-knee mass described as a tumor, which specialist should I refer her to and should I order an MRI?
A 21-year-old female presents with central pricking chest pain that worsens when lying supine and improves on sitting up, accompanied by shortness of breath, tachycardia (heart rate 105 bpm), borderline hypotension (blood pressure 100/60 mmHg), and oxygen saturation 99%; what is the most likely diagnosis?
What does a high urinary iodine concentration with low serum iron and low transferrin‑iron saturation indicate?
Is it normal for a previously perforated tympanic membrane (eardrum) to heal with a brown scab-like area over the eardrum?
In a patient with congestive heart failure, hypertension, and hyperlipidemia who has a urinary tract infection characterized by alkaline urine (pH >9), turbid appearance, positive nitrites, numerous bacteria (too numerous to count), triple phosphate crystals, and 6–10 white blood cells per high‑power field, what is the appropriate antibiotic choice if ciprofloxacin is contraindicated?
In a non‑pregnant woman under 65 years old, what clinical criteria allow diagnosis of acute uncomplicated cystitis without obtaining a urine culture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.